GlassScriptPhysician profile
Charles J Harrison
NPI 1760971816
$722.11
in general payments reported to CMS, 2019-2025
9 companies · $168 in 2025
The $168 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $213 · 2023: $208 · 2024: $133 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $509.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $272.84 | 2022-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $205.67 | 2022-2025 | Rybelsus, Ozempic, Tresiba |
| Insmed, INC. | $68.90 | 2023-2025 | Arikayce |
| Radius Health, INC. | $45.60 | 2024 | |
| Medline Industries LP | $44.26 | 2025 | |
| Mallinckrodt Hospital Products INC. | $35.78 | 2024-2025 | Acthar |
| Exact Sciences Corporation | $17.46 | 2023 | Cologuard Collection Kit |
| Medtronic, INC. | $16.16 | 2023 | Intellis Adaptivestim |
| Glaxosmithkline, LLC. | $15.44 | 2024 | Trelegy Ellipta, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.